Participants taking higher doses of Retatrutide experienced an increase in heart rate during the first 24 weeks, after which it decreased
Seek urgent medical attention (call 999 or go to A&E) if you experience: Chest pain or tightness, particularly if radiating to the arm, jaw, or back Sudden shortness of breath at rest or with minimal exertion Palpitations accompanied by dizziness, fainting, or loss of consciousness Rapid or irregular heartbeat that does not resolve within a few minutes Sudden swelling of the legs or ankles combined with breathlessness (possible signs of heart failure) If you need urgent medical advice and it is not life-threatening, call NHS 111 or use 111 online
Assuming it follows similar patterns, retatrutide most likely wont be recommended for people with : A history of pancreatitis Thyroid cancer or multiple endocrine neoplasia syndrome Severe kidney problems Severe liver issues Worried about side effects
has served as a consultant for Jazz Pharmaceuticals, Lilly, Apnimed, Axsome and Mineralys
Meaningful weight reduction is generally observed by weeks 12 to 16, with maximum weight loss tending to occur later in the treatment period, depending on the agent and dose
It allows a wider variety of patients to experience the benefits of GLP-1 drugs, says Dr
